These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 2594368
1. High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Bongarzone I, Pierotti MA, Monzini N, Mondellini P, Manenti G, Donghi R, Pilotti S, Grieco M, Santoro M, Fusco A. Oncogene; 1989 Dec; 4(12):1457-62. PubMed ID: 2594368 [Abstract] [Full Text] [Related]
2. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Fugazzola L, Pilotti S, Pinchera A, Vorontsova TV, Mondellini P, Bongarzone I, Greco A, Astakhova L, Butti MG, Demidchik EP. Cancer Res; 1995 Dec 01; 55(23):5617-20. PubMed ID: 7585643 [Abstract] [Full Text] [Related]
3. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas. Greco A, Pierotti MA, Bongarzone I, Pagliardini S, Lanzi C, Della Porta G. Oncogene; 1992 Feb 01; 7(2):237-42. PubMed ID: 1532241 [Abstract] [Full Text] [Related]
4. Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas. Castellone MD, Guarino V, De Falco V, Carlomagno F, Basolo F, Faviana P, Kruhoffer M, Orntoft T, Russell JP, Rothstein JL, Fusco A, Santoro M, Melillo RM. Oncogene; 2004 Aug 05; 23(35):5958-67. PubMed ID: 15184868 [Abstract] [Full Text] [Related]
6. The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line. Santoro M, Melillo RM, Grieco M, Berlingieri MT, Vecchio G, Fusco A. Cell Growth Differ; 1993 Feb 05; 4(2):77-84. PubMed ID: 8494786 [Abstract] [Full Text] [Related]
7. Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens. Notario V, Castro R, Flessate DM, Doniger J, DiPaolo JA. Oncogene; 1990 Sep 05; 5(9):1425-30. PubMed ID: 2216466 [Abstract] [Full Text] [Related]
8. Gene rearrangements in radiation-induced thyroid carcinogenesis. Rabes HM. Med Pediatr Oncol; 2001 May 05; 36(5):574-82. PubMed ID: 11340615 [Abstract] [Full Text] [Related]
9. [Thyroid carcinoma]. Namba H, Izumi M. Gan To Kagaku Ryoho; 1991 Jan 05; 18(1):22-9. PubMed ID: 1987898 [Abstract] [Full Text] [Related]
10. Identification and expression of human c-Ha-ras and c-sis sequences in NIH3T3 transformants. Weismanová E, Sabová L. Neoplasma; 1990 Jan 05; 37(6):675-85. PubMed ID: 2274086 [Abstract] [Full Text] [Related]
11. Rearrangements of NTRK1 oncogene in papillary thyroid carcinoma. Brzeziańska E, Pastuszak-Lewandoska D, Lewiński A. Neuro Endocrinol Lett; 2007 Jun 05; 28(3):221-9. PubMed ID: 17627253 [Abstract] [Full Text] [Related]
12. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium. Russell JP, Powell DJ, Cunnane M, Greco A, Portella G, Santoro M, Fusco A, Rothstein JL. Oncogene; 2000 Nov 23; 19(50):5729-35. PubMed ID: 11126359 [Abstract] [Full Text] [Related]
13. Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells. Castellone MD, Celetti A, Guarino V, Cirafici AM, Basolo F, Giannini R, Medico E, Kruhoffer M, Orntoft TF, Curcio F, Fusco A, Melillo RM, Santoro M. Oncogene; 2004 Mar 18; 23(12):2188-96. PubMed ID: 14981541 [Abstract] [Full Text] [Related]
14. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Della Porta G, Fusco A, Vecchio G. Cell; 1990 Feb 23; 60(4):557-63. PubMed ID: 2406025 [Abstract] [Full Text] [Related]
15. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule. Albor A, Thraves PJ, Dritschilo A, Notario V. Oncogene; 1996 Oct 17; 13(8):1755-63. PubMed ID: 8895522 [Abstract] [Full Text] [Related]
16. Ret/PTC3 is the most frequent form of gene rearrangement in papillary thyroid carcinomas in Japan. Kitamura Y, Minobe K, Nakata T, Shimizu K, Tanaka S, Fujimori M, Yokoyama S, Ito K, Onda M, Emi M. J Hum Genet; 1999 Oct 17; 44(2):96-102. PubMed ID: 10083732 [Abstract] [Full Text] [Related]
17. Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Schmidt L, Junker K, Nakaigawa N, Kinjerski T, Weirich G, Miller M, Lubensky I, Neumann HP, Brauch H, Decker J, Vocke C, Brown JA, Jenkins R, Richard S, Bergerheim U, Gerrard B, Dean M, Linehan WM, Zbar B. Oncogene; 1999 Apr 08; 18(14):2343-50. PubMed ID: 10327054 [Abstract] [Full Text] [Related]
18. Rearrangements of NTRK1 gene in papillary thyroid carcinoma. Greco A, Miranda C, Pierotti MA. Mol Cell Endocrinol; 2010 May 28; 321(1):44-9. PubMed ID: 19883730 [Abstract] [Full Text] [Related]
19. Oncogenes and growth factors in thyroid carcinogenesis. Frauman AG, Moses AC. Endocrinol Metab Clin North Am; 1990 Sep 28; 19(3):479-93. PubMed ID: 2175702 [Abstract] [Full Text] [Related]
20. Tumorigenicity assay of the human mammary carcinoma cell line MCF-7. Marics I, Adelaide J, Rosnet O, Planche J, Pirisi V, Birnbaum D. Anticancer Res; 1989 Sep 28; 9(6):1627-31. PubMed ID: 2560622 [Abstract] [Full Text] [Related] Page: [Next] [New Search]